β-Nicotinamide Mononucleotide (NMN) Market Share Driven by Expanding Health Supplement Adoption and Advanced Biochemical Manufacturing | Valuates Reports

β-Nicotinamide Mononucleotide (NMN) Market Size
The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16K9169/Global_%CE%B2_Nicotinamide_Mononucleotide_NMN_Market_Insights_and_Forecast_to_2028

The β-Nicotinamide Mononucleotide (NMN) Market is experiencing notable market growth as interest in cellular health, healthy aging, and metabolic support continues to rise across global consumer segments. Market trends show increasing integration of NMN into premium health formulations, supported by advancements in biochemical synthesis, fermentation technologies, and purity control. Growing consumer awareness, evolving regulatory clarity in a shift toward preventive healthcare are collectively influencing market size and purchasing behavior.

By type, NMN with content at or above high-purity standards holds the largest market share, as it is preferred for health care products and cosmetic formulations that demand consistency, safety, and bioavailability. This segment benefits from stringent quality expectations and brand positioning in premium wellness categories. NMN with lower purity content is expanding steadily, particularly in applications where formulation flexibility and cost considerations play a larger role. Together, these type segments shape overall market growth and product differentiation strategies.

From an application perspective, health care products dominate the market share, driven by the widespread use of NMN in targeting energy metabolism and cellular function. Cosmetics represent the fastest-growing application, supported by rising demand for anti-aging and skin vitality formulations incorporating bioactive ingredients. Other applications contribute to market size through niche wellness and research-driven use cases, reinforcing diversified demand patterns.

The competitive landscape includes both established nutraceutical specialists and emerging biotechnology firms. GeneHarbor and Kingdomway maintain strong market share through integrated production capabilities and consistent quality output. Companies such as Herbalmax, Bontac, and Mirailab Bioscience continue to expand rapidly by focusing on high-purity production, formulation expertise, and global distribution partnerships. Emerging players including Genex Formulas, CELFULL, and EffePharm strengthen competitive positioning through innovation, branding, and targeted market expansion strategies.

Regionally, Asia-Pacific leads the market share, supported by large-scale production capacity, advanced biochemical manufacturing ecosystems, and strong consumer adoption in functional nutrition. North America follows closely, driven by mature markets and growing interest in longevity-focused health solutions. Europe is showing accelerating market growth, influenced by premium wellness consumption and regulatory alignment in nutraceuticals. The market forecast remains optimistic, underpinned by ongoing innovation, capacity expansion, broader application development, and sustained global demand for science-backed wellness ingredients.

by Type

• Content ≥98%
• Content

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.